Glucagon‐like peptide agonists: A prospective review

Article Properties
Abstract
Cite
Mariam, Zamara, and Sarfaraz K. Niazi. “Glucagon‐like Peptide Agonists: A Prospective Review”. Endocrinology, Diabetes &Amp; Metabolism, vol. 7, no. 1, 2023, https://doi.org/10.1002/edm2.462.
Mariam, Z., & Niazi, S. K. (2023). Glucagon‐like peptide agonists: A prospective review. Endocrinology, Diabetes &Amp; Metabolism, 7(1). https://doi.org/10.1002/edm2.462
Mariam, Zamara, and Sarfaraz K. Niazi. “Glucagon‐like Peptide Agonists: A Prospective Review”. Endocrinology, Diabetes &Amp; Metabolism 7, no. 1 (2023). https://doi.org/10.1002/edm2.462.
Mariam Z, Niazi SK. Glucagon‐like peptide agonists: A prospective review. Endocrinology, Diabetes & Metabolism. 2023;7(1).
Journal Category
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the endocrine glands
Clinical endocrinology
Refrences
Title Journal Journal Categories Citations Publication Date
Striking the balance: GLP‐1/glucagon Co‐Agonism as a treatment strategy for obesity 2021
Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes 2010
Structural requirements for the occupancy of pituitary adenylate cyclase‐activating peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB‐OK‐1 cell membranes 1988
Effects of glucagon‐like Peptide‐1 analogs on sexual desire: a randomized, double‐blind, placebo‐controlled crossover trial 2023
GLP‐1 receptor agonists for Parkinson's disease 2020
Citations
Title Journal Journal Categories Citations Publication Date
Chemerin in Participants with or without Insulin Resistance and Diabetes

 Biomedicines
  • Science: Biology (General)
  • Science: Biology (General)
  • Medicine: Medicine (General)
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 2024
Special Issue: “Anti-inflammatory Effects of Glucagon-like Peptide-1”

 International Journal of Molecular Sciences
  • Science: Biology (General)
  • Science: Chemistry: General. Including alchemy
  • Science: Chemistry
 2024
Glucagon-like peptide-1 receptor agonists: Рrospects for use in rheumatology

 Rheumatology Science and Practice
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the musculoskeletal system
 2024
Citations Analysis
Category Category Repetition
Science: Biology (General)2
Science: Chemistry: General. Including alchemy1
Science: Chemistry1
Medicine: Medicine (General)1
Medicine: Therapeutics. Pharmacology1
Medicine: Public aspects of medicine: Toxicology. Poisons1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the musculoskeletal system1
The category Science: Biology (General) 2 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Glucagon-like peptide-1 receptor agonists: Рrospects for use in rheumatology and was published in 2024. The most recent citation comes from a 2024 study titled Glucagon-like peptide-1 receptor agonists: Рrospects for use in rheumatology. This article reached its peak citation in 2024, with 3 citations. It has been cited in 3 different journals, 66% of which are open access. Among related journals, the Rheumatology Science and Practice cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year